Targeted Drug Delivery and Nanocarriers
A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Medicinal Chemistry".
Deadline for manuscript submissions: closed (10 April 2018) | Viewed by 65030
Special Issue Editors
Interests: human and veterinary pharmaceuticals; advanced drug delivery; cancer; infection; 3D printing
Special Issues, Collections and Topics in MDPI journals
Interests: controlled drug delivery; polymeric nanoparticles; liposomes; nanoemulsions; lipid nanoparticles; chronotherapeutics; solubility enhancement
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Nanocarriers are widely explored systems for diagnostic and various drug delivery applications. Among the controlled drug delivery technologies, targeted drug delivery has attracted the attention of researchers, as it comprises the systemic delivery of the drug-carrier system to specific cell types, tissues, or organs. Multifunctional capabilities of nanocarriers make them suitable for the targeted delivery of drugs with diverse nature, including proteins, peptides, or DNA. Polymeric/lipid-based nanoparticles, nanocomposites, nanofibres, and carbon nanotubes are a few examples of nanocarriers which are used extensively. The surface of the nanoparticles is modified or conjugated with the suitable ligands for targetingin order to minimise the opsonization and to prolong the circulation time. Targeted nanoparticulate delivery would mainly be beneficial in diseases like cancer and diseases related to the brain.
In this Special Issue, articles are invited to provide a recent insight into the nanocarriers which are useful for targeted drug delivery.
Prof. Sanjay GargDr. Usha Y Nayak
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- dug delivery
- targeting
- nanoparticles
- functionalization
- conjugation
- cancer therapy
- brain targeting
- lymphatic targeting
- hepatic targeting